Natroba
Payments companies reported to CMS as associated with Natroba. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Natroba, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Natroba
These are the largest totals companies reported as associated with Natroba. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Belcher | Carmel, IN | Pediatric Infectious Diseases | $37,282.00 |
| Anthony Mancini | Chicago, IL | Pediatrics | $32,868.00 |
| Scott Guenthner | Plainfield, IN | Dermatology | $17,200.00 |
| Angela Pierce | Indianapolis, IN | Nurse Practitioner | $17,113.85 |
| Christina Feser | Clarksville, TN | Dermatology | $8,500.00 |
| Sanjosh Singh | Brooklyn, NY | Dermatology | $3,600.00 |
| Rawaa Almukhtar | La Jolla, CA | Dermatology | $2,534.12 |
| Axel Martinez Irizarry | Ballinger, TX | Family Medicine | $2,000.00 |
| Shanna Miranti | Naples, FL | Medical | $1,900.00 |
| Hector Dicarlo | Fort Lauderdale, FL | Family Medicine | $1,017.79 |
Prescribed Natroba?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.